Japan, Jan. 28 -- PHARMACYLICS LLC has got intellectual property rights for 'USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK).' Other related details are as follows:

Application Number: JP,2023-203240

Category (FI): A61K31/196,A61K31/282,A61K31/337,A61K31/4184,A61K31/436,A61K31/4439,A61K31/454,A61K31/475,A61K31/519,A61K31/52,A61K31/5383,A61K31/573,A61K31/675,A61K31/69,A61K31/704,A61K31/7048,A61K31/7056,A61K31/7068,A61K31/7076,A61K39/395@T,A61K45/00,A61K9/20,A61K9/48,A61P35/00,A61P43/00,111,A61P43/00,121

Stage: Grant (IP right document published.)

Filing Date: Nov. 30, 2023

Publication Date: March 5, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....